Latest from TCT 2017

LAA Closure vs Warfarin for Stroke Prevention in Atrial Fibrillation

LAA Closure vs Warfarin for Stroke Prevention in Atrial Fibrillation

A left atrial appendage closure device provided a similar level of stroke prevention to that of warfarin in patients with atrial fibrillation.

Culprit Lesion PCI Superior to Immediate Multivessel PCI in CAD

Culprit Lesion PCI Superior to Immediate Multivessel PCI in CAD

Percutaneous coronary intervention of the culprit lesion is associated with better 30-day outcomes than immediate multivessel PCI in patients with patients with multivessel CAD and acute MI.

Target Vessel Thrombosis in BVS vs Everolimus-Eluting Stents

Target Vessel Thrombosis in BVS vs Everolimus-Eluting Stents

Patients who received bioresorbable vascular scaffolds had higher rates of device thrombosis and target vessel MI compared with those who received everolimus-eluting stents.

Vessel Sizing Optimization in BVS Implantation

Vessel Sizing Optimization in BVS Implantation

Researchers analyzed 3-year outcomes in patients implanted with bioresorbable vascular scaffolds for the treatment of coronary lesions.

PCI and CABG Provide Similar Intermediate-Term Outcomes in Left Main CAD

PCI and CABG Provide Similar Intermediate-Term Outcomes in Left Main CAD

A substudy analyzed whether PCI outcomes using second generation drug eluting stents were comparable to CABG in patients with low or intermediated complexity left main coronary artery disease.

Upcoming Meetings

Sign Up for Free e-Newsletters